News | Defibrillator Monitors | June 23, 2020

FDA Grants Premarket Clearance for Philips HeartStart FR3 and HeartStart FRx Automated Defibrillators

Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.

Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.


June 23, 2020 — Philips announced the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company’s HeartStart FR3 (models 861388 and 861389) and HeartStart FRx (model 861304) automated external defibrillators (AEDs), and their supporting accessories, including batteries and pads.

The HeartStart FR3 is a professional grade AED with advanced features to help medical personnel and first-responders treat cardiac arrest. The HeartStart FRx is a public-access AED that features intuitive, step-by-step voice instructions, including cardiopulmonary resuscitation (CPR) guidance, for emergency use in workplaces, schools and other public spaces, as well as for medical professional use.

“We are pleased to receive premarket approval for our HeartStart FR3 and HeartStart FRx AEDs,” said Arman Voskerchyan, business leader, therapeutic care at Philips. “This complements the premarket approval that we received last year for our HeartStart OnSite and HeartStart Home AEDs. Our industry leading portfolio of AEDs is instrumental in helping save the lives of numerous sudden cardiac arrest victims in the U.S. and worldwide. We look forward to continuing to meet our commitment to our medical professional and public-access customers, and especially to the victims of sudden cardiac arrest who rely on our AEDs.”

FDA PMA information for the HeartStart FR3 and HeartStart FRx defibrillators can be found here and here, respectively. These devices have been marketed to date under FDA 510(k) premarket notifications, but are now approved under PMA.

In 2019, Philips received PMA approval for its HeartStart OnSite and HeartStart Home defibrillators, which are the only over-the-counter AEDs available to consumers in the U.S.
 

Related Content

News | Defibrillator Monitors

April 24, 2020 — The U.S. Food and Drug Administration (FDA) has lifted its injunction prohibiting the manufacturing and ...

Home April 24, 2020
Home
News | Defibrillator Monitors

January 13, 2020 — Stryker announced it is launching a voluntary field action on specific units of the LifePAK 15 ...

Home January 13, 2020
Home
Technology | Defibrillator Monitors

June 19, 2019 — Philips announced the U.S. Food and Drug Administration (FDA) has approved the company’s premarket ...

Home June 19, 2019
Home
News | Defibrillator Monitors

April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the 2019 American College ...

Home April 05, 2019
Home
Feature | Defibrillator Monitors

February 4, 2019 — Stryker announced Feb. 1, the company is launching a voluntary field action on specific units of the ...

Home February 04, 2019
Home
Feature | Defibrillator Monitors | Michael J. Mirro, M.D.

Following the Vest Prevention of Early Sudden Death Trial (VEST) presentation at the 2018 American College of Cardiology ...

Home July 10, 2018
Home
News | Defibrillator Monitors

June 27, 2018 — Wearable cardioverter defibrillators may be a safe and effective alternative to surgically implanted ...

Home June 27, 2018
Home
News | Defibrillator Monitors

April 16, 2018 — The skin presents a formidable barrier to life-saving defibrillators, but a team of students from Rice ...

Home April 16, 2018
Home
News | Defibrillator Monitors

October 16, 2017 — Zoll Canada, a subsidiary of Zoll Medical Corp., announced it has won the tender to equip all ...

Home October 16, 2017
Home
Technology | Defibrillator Monitors

April 24, 2017 — Physio-Control announced April 19 that the company’s HeartSine samaritan PAD 360P (SAM 360P) fully ...

Home April 24, 2017
Home
Subscribe Now